Download Dr. Mario Rocci's presentation "Confirmatory Re-Analysis of Incurred Samples - An Industry Perspective". This talk was presented at the 2007 AAPS National Biotechnology Conference in San Diego, CA
Mr. Mike Coon joins Prevalere Life Sciences Inc. as Manager, Business Development.
Prevalere CEO, Mario L. Rocci Jr., Ph.D., serves as Guest Editor of the themed issue of The AAPS Journal entitled, Bioanalytical Method Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays. Drs. Haughey and Jardieu of Prevalere Life Sciences, Inc. contributed to this issue of the Journal.
Prevalere Life Sciences, Inc. enters strategic partnership with BioPharma Services, Inc. a 50,000 sf Phase I/Bioequivalence Unit. This alliance enables Prevalere Life Sciences,Inc. to offer full support for Phase I and Bioequivalence studies.
For more information on BioPharma Services Inc. please visit http://www.biopharmaservices.ca
Please visit us at the following upcoming meetings:
17th Annual Partnerships with CROs and Other Outsourcing Providers, Booth #800, Mandalay Bay, Las Vegas, NV, April 14-16, 2008
AAPS National Biotechnology Meeting, Booth #501, Metro Toronto Convention Centre, Toronto, ON, June 22-25, 2008
Prevalere adds Bioassay services to its suite of biotechnology services.
This service area uses a wide variety of cell culture techniques for your in vitro assay needs. These extensive capabilities permit assessment of the functional activity of your biologic in a timely and customized manner. For more information click here.
